Name: UMIN ID:
Unique ID issued by UMIN | UMIN000014740 |
---|---|
Receipt number | R000017132 |
Scientific Title | Phase 2 study of efficacy and safety of concurrent WBRT with erlotinib and followed by erlotinib plus bevacizumab in patients with newly diagnostic brain metastatisis stage IV non-sq NSCLC |
Date of disclosure of the study information | 2014/09/01 |
Last modified on | 2015/02/04 19:25:33 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2014/08/01 17:55:45 | ||
2 | Update | 2015/02/04 19:25:33 | Interventions/Control_1 Interventions/Control_1 Key exclusion criteria Key exclusion criteria |